Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16)-Reference-Cited by-同舟云学术

Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16)

Published:2005-07 Issue:2 Volume:130 Page:218-228
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Bruenke Joerg,Barbin Karin,Kunert Susanne,Lang Peter,Pfeiffer Matthias,Stieglmaier Kristin,Niethammer Dietrich,Stockmeyer Bernhard,Peipp Matthias,Repp Roland,Valerius Thomas,Fey Georg H.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2005.05414.x/fullpdf

Reference49 articles.

1. Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay

2. Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies

3. A recombinant immunotoxin containing a disulfide-stabilized Fv fragment.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. iPSCs in NK Cell Manufacturing and NKEV Development;Frontiers in Immunology;2022-07-08

2. The War Is on: The Immune System against Glioblastoma—How Can NK Cells Drive This Battle?;Biomedicines;2022-02-08

3. T-cell engaging bispecific antibody therapy;Cancer Immunology and Immunotherapy;2022

4. CD19 epitope masking by tafasitamab leads to delays in subsequent use of CD19 CAR T-cell therapy in two patients with aggressive mature B-cell lymphomas;Leukemia & Lymphoma;2021-12-23

5. Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy;Journal of Leukocyte Biology;2020-09-29